Currently Enrolling Trials





Active Clinical Trials (Closed for enrollment)

  • A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration (Alcon HAWK trial)

    https://clinicaltrials.gov/ct2/show/NCT02307682




  • A randomized, multi-center, single masked, sham controlled, proof-of –concept study of intravitreal CLG561 as a monotherapy or in combination with LFG316 in patents with geographic atrophy (Alcon CLG561)

    https://clinicaltrials.gov/ct2/show/NCT02515942


  • A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Pilot Study to Evaluate Effects of Emixustat Hydrochloride on Aqueous Humor Biomarkers Associated With Proliferative Diabetic Retinopathy

    https://clinicaltrials.gov/ct2/show/NCT02753400



  • Study of Comparative Treatments for Retinal Vein Occlusion 2 [SCORE2]: a Multicenter, Prospective, Randomized Non-inferiority Trial of Eyes With Macular Edema Secondary to Central Retinal Vein Occlusion, Comparing Intravitreal Bevacizumab Every 4 Weeks With Intravitreal Aflibercept Every 4 Weeks.

    https://clinicaltrials.gov/ct2/show/NCT01969708